US Broker Ratings

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking a 245% Potential Upside in Biotech

Viking Therapeutics, Inc. (NASDAQ: VKTX), a promising player in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of clinical-stage therapeutics. Headquartered..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Challenges in the Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) presents a unique case for investors seeking opportunities within the healthcare sector, specifically in the medical instruments and supplies industry. With..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a Potential 184% Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biopharmaceutical company specializing in monoclonal antibodies for autoimmune diseases, has recently caught the eye of investors with a notable potential..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Analysts See Nearly 37% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a dynamic player in the biotechnology sector, has been capturing investor attention with its promising pipeline and potential for significant stock..

PROCEPT BioRobotics (PRCT) Stock Analysis: Unpacking a 32.68% Upside Potential

For investors keen on the healthcare sector, particularly in the realm of medical devices, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a compelling opportunity. This San Jose-based..

Zai Lab Limited (ZLAB) Stock Analysis: Unpacking a 77% Potential Upside in Biotech Investment

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, has been drawing significant attention from investors due to its promising pipeline and strategic..

Amedisys Inc (AMED) Stock Analysis: Navigating Growth in Healthcare with a 2.51% Potential Upside

Amedisys Inc (NASDAQ: AMED), a prominent player in the healthcare sector, is making waves with its specialized services in home health, hospice, and high acuity care...

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Growth Challenges with a 16% Upside Potential

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing investment opportunity despite its recent..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Potential Upside of Over 53% Amid Strong Analyst Ratings

Investors eyeing the healthcare sector may find Akero Therapeutics, Inc. (NASDAQ: AKRO) a compelling opportunity, particularly given its robust analyst ratings and potential upside. With a..

Grifols, S.A. (GRFS) Stock Analysis: Assessing Its 30% Potential Upside and Strategic Growth in Healthcare

For investors keeping a close eye on the healthcare sector, Grifols, S.A. (NASDAQ: GRFS) presents a compelling opportunity, particularly with its potential upside of 30.39% based..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Potential 67.87% Upside in Biotech Innovation

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with its promising potential upside of 67.87%, poised to make waves in the biotechnology industry...

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Promising Biotech with 17% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to treating B-cell mediated diseases. With..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Potential Upside and Growth Prospects in Biotech

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the competitive biotechnology sector with its impressive growth metrics and strategic collaborations, making it a compelling consideration for..

Soleno Therapeutics, Inc. (SLNO) Investor Outlook: Analyzing a 51% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector should take a closer look at Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company making waves..

Verona Pharma plc (VRNA): Exploring the 15.89% Potential Upside with Strong Buy Ratings

Verona Pharma plc (NASDAQ: VRNA), a prominent player in the biotechnology sector, continues to capture investor attention with its promising portfolio aimed at treating respiratory diseases..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 38% Potential Upside in the Biotech Space

Telix Pharmaceuticals Limited (TLX), an emerging leader in the biotechnology sector, is capturing the attention of investors with its promising portfolio of radiopharmaceuticals targeting cancer and..

Oscar Health, Inc. (OSCR): Investor Outlook on a Stock with 40.81% Potential Upside

Oscar Health, Inc. (NYSE: OSCR), a burgeoning player in the healthcare plans sector, presents a compelling case for investors seeking growth in the healthcare technology landscape...

Alkermes plc (ALKS) Investor Outlook: A 30.46% Potential Upside in the Dynamic Healthcare Sector

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, offers a compelling investment opportunity for those looking to capitalize on the biopharmaceutical industry’s growth...

Avidity Biosciences, Inc. (RNA) Stock Analysis: Unveiling a 115% Upside Potential

Avidity Biosciences, Inc. (NASDAQ: RNA) is attracting significant attention in the biotechnology sector, thanks to its innovative approach to RNA therapeutics and a potential upside of..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Exploring a Potential 62.91% Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a significant player in the healthcare sector, specifically within the biotechnology industry. The company’s innovative approach towards treating..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds